These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 30143460)

  • 1. COPD assessment test as a possible tool for evaluating health-related quality of life in lymphangioleiomyomatosis.
    Kato M; Kanehiro Y; Yoshimi K; Kodama Y; Sekiya M; Sato T; Takahashi K; Seyama K;
    Respir Investig; 2018 Nov; 56(6):480-488. PubMed ID: 30143460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term efficacy and safety of sirolimus therapy in patients with lymphangioleiomyomatosis.
    Hu S; Wu X; Xu W; Tian X; Yang Y; Wang ST; Liu S; Xu X; Xu KF
    Orphanet J Rare Dis; 2019 Aug; 14(1):206. PubMed ID: 31429781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is sirolimus a therapeutic option for patients with progressive pulmonary lymphangioleiomyomatosis?
    Neurohr C; Hoffmann AL; Huppmann P; Herrera VA; Ihle F; Leuschner S; von Wulffen W; Meis T; Baezner C; Leuchte H; Baumgartner R; Zimmermann G; Behr J
    Respir Res; 2011 May; 12(1):66. PubMed ID: 21600034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The St. George's Respiratory Questionnaire in lymphangioleiomyomatosis.
    Xu KF; Wang L; Tian XL; Gui YS; Peng M; Cai BQ; Zhu YJ
    Chin Med Sci J; 2010 Sep; 25(3):140-5. PubMed ID: 21180274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. St. George's Respiratory Questionnaire has longitudinal construct validity in lymphangioleiomyomatosis.
    Swigris JJ; Lee HS; Cohen M; Inoue Y; Moss J; Singer LG; Young LR; McCormack FX;
    Chest; 2013 Jun; 143(6):1671-1678. PubMed ID: 23328755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the MILES cohort reveals determinants of disease progression and treatment response in lymphangioleiomyomatosis.
    Gupta N; Lee HS; Young LR; Strange C; Moss J; Singer LG; Nakata K; Barker AF; Chapman JT; Brantly ML; Stocks JM; Brown KK; Lynch JP; Goldberg HJ; Downey GP; Taveira-DaSilva AM; Krischer JP; Setchell K; Trapnell BC; Inoue Y; McCormack FX;
    Eur Respir J; 2019 Apr; 53(4):. PubMed ID: 30846465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained effects of sirolimus on lung function and cystic lung lesions in lymphangioleiomyomatosis.
    Yao J; Taveira-DaSilva AM; Jones AM; Julien-Williams P; Stylianou M; Moss J
    Am J Respir Crit Care Med; 2014 Dec; 190(11):1273-82. PubMed ID: 25329516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The COPD assessment test and St George's Respiratory Questionnaire: are they equivalent in subjects with COPD?
    Morishita-Katsu M; Nishimura K; Taniguchi H; Kimura T; Kondoh Y; Kataoka K; Ogawa T; Watanabe F; Arizono S; Nishiyama O; Nakayasu K; Imaizumi K; Hasegawa Y
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1543-51. PubMed ID: 27462150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Novel Quantitative Computed Tomographic Analysis Suggests How Sirolimus Stabilizes Progressive Air Trapping in Lymphangioleiomyomatosis.
    Argula RG; Kokosi M; Lo P; Kim HJ; Ravenel JG; Meyer C; Goldin J; Lee HS; Strange C; McCormack FX;
    Ann Am Thorac Soc; 2016 Mar; 13(3):342-9. PubMed ID: 26799509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional improvements in patients with lymphangioleiomyomatosis after sirolimus: an observational study.
    Zhan Y; Shen L; Xu W; Wu X; Zhang W; Wang J; Li X; Yang Y; Tian X; Xu KF
    Orphanet J Rare Dis; 2018 Feb; 13(1):34. PubMed ID: 29458386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum VEGF-D a concentration as a biomarker of lymphangioleiomyomatosis severity and treatment response: a prospective analysis of the Multicenter International Lymphangioleiomyomatosis Efficacy of Sirolimus (MILES) trial.
    Young L; Lee HS; Inoue Y; Moss J; Singer LG; Strange C; Nakata K; Barker AF; Chapman JT; Brantly ML; Stocks JM; Brown KK; Lynch JP; Goldberg HJ; Downey GP; Swigris JJ; Taveira-DaSilva AM; Krischer JP; Trapnell BC; McCormack FX;
    Lancet Respir Med; 2013 Aug; 1(6):445-52. PubMed ID: 24159565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional performance in patients with COPD: association with treatment regimen, GOLD group, lung function, and symptom burden in a cross-sectional study.
    Ding B; Judge D; Small M; Bent-Ennakhil N; Siddiqui S
    Int J Chron Obstruct Pulmon Dis; 2018; 13():2785-2796. PubMed ID: 30233169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced physical activity in lymphangioleiomyomatosis compared with COPD and healthy controls: disease-specific impact and clinical correlates.
    Bahmer T; Watz H; Waschki B; Gramm M; Magnussen H; Rabe KF; Wirtz H; Kirsten D; Kirsten A
    Thorax; 2016 Jul; 71(7):662-3. PubMed ID: 26968971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of a linear analog scale questionnaire to measure health-related quality of life in elderly patients with chronic obstructive pulmonary disease.
    Katsura H; Yamada K; Kida K
    J Am Geriatr Soc; 2003 Aug; 51(8):1131-5. PubMed ID: 12890078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study of the clinical phenotype of symptomatic chronic airways disease by hierarchical cluster analysis and two-step cluster analyses].
    Ning P; Guo YF; Sun TY; Zhang HS; Chai D; Li XM
    Zhonghua Nei Ke Za Zhi; 2016 Sep; 55(9):679-83. PubMed ID: 27586974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis.
    Bissler JJ; McCormack FX; Young LR; Elwing JM; Chuck G; Leonard JM; Schmithorst VJ; Laor T; Brody AS; Bean J; Salisbury S; Franz DN
    N Engl J Med; 2008 Jan; 358(2):140-51. PubMed ID: 18184959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of different evaluation systems for assessing disease severity and treatment efficacy in patients with chronic obstructive pulmonary disease].
    Tan M; Jian W; Liang Q; Li S; Cui H
    Nan Fang Yi Ke Da Xue Xue Bao; 2021 Jul; 41(7):1119-1124. PubMed ID: 34308866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitrogen single-breath washout test for evaluating exercise tolerance and quality of life in patients with chronic obstructive pulmonary disease.
    Deus CAL; Vigário PS; Guimarães FS; Lopes AJ
    Braz J Med Biol Res; 2018; 51(4):e7059. PubMed ID: 29490001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors Associated With Quality of Life in Subjects With Stable COPD.
    Ekici A; Bulcun E; Karakoc T; Senturk E; Ekici M
    Respir Care; 2015 Nov; 60(11):1585-91. PubMed ID: 26152471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Correlation among the levels of C-reactive protein and interleukin-18, quality of life, and lung function in patients with chronic obstructive pulmonary disease].
    Long H; Luo H; Chen P; Li Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Nov; 36(11):1090-6. PubMed ID: 22169727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.